Sun R, Wang Y, Shu H, Li L, et al. Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial. Diabetes Obes Metab 2025 Nov 10. doi: 10.1111/dom.70262.
PMID: 41208635